Autophagy Reduces Acute Ethanol-Induced Hepatotoxicity and Steatosis in Mice
Background & Aims
Alcohol abuse is a major cause of liver injury. The pathologic features of alcoholic liver disease develop over prolonged periods, yet the cellular defense mechanisms against the detrimental effects of alcohol are not well understood. We investigated whether macroautophagy, an evolutionarily conserved cellular mechanism that is commonly activated in response to stress, could protect liver cells from ethanol toxicity.
Methods
Mice were acutely given ethanol by gavage. The effects of ethanol on primary hepatocytes and hepatic cell lines were also studied in vitro.
Results
Ethanol-induced macroautophagy in the livers of mice and cultured cells required ethanol metabolism, generation of reactive oxygen species, and inhibition of mammalian target of rapamycin signaling. Suppression of macroautophagy with pharmacologic agents or small interfering RNAs significantly increased hepatocyte apoptosis and liver injury; macroautophagy therefore protected cells from the toxic effects of ethanol. Macroautophagy induced by ethanol seemed to be selective for damaged mitochondria and accumulated lipid droplets, but not long-lived proteins, which could account for its protective effects. Increasing macroautophagy pharmacologically reduced hepatotoxicity and steatosis associated with acute ethanol exposure.
Conclusions
Macroautophagy protects against ethanol-induced toxicity in livers of mice. Reagents that modify macroautophagy might be developed as therapeutics for patients with alcoholic liver disease.
Keywords: GFP-LC3, Bodipy Staining, Autophagy Flux, Long-Lived Protein Degradation
Abbreviations used in this paper: 3-MA, 3-methyladenine, 4-MP, 4-methyl pyrazole, ADH, alcohol dehydrogenase, ALT, alanine aminotransferase, CYP2E1, cytochrome P450 2E1, CQ, chloroquine, EM, electron microscopy, LD, lipid droplets, MnTBAP, manganese (III) tetrakis (4-benzoic acid) porphyrin chloride, mTOR, mammalian target of rapamycin, MTR, MitoTracker Red, NAC, N-acetylcysteine, PE, phosphatidylethanolamine, siRNA, small interfering RNA, ROS, reactive oxygen species
To access this article, please choose from the options below
Conflicts of interest The authors disclose no conflicts.
Funding Supported in part by NIH (R01 CA83817, R01 CA111456 to X.-M.Y.; R01 AA11291 to D.L.C.; R21 AA017421 to W.-X.D.) and the Department of Veterans Affairs (to D.L.C.).
PII: S0016-5085(10)01104-2
doi:10.1053/j.gastro.2010.07.041
© 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

